Cargando…

Utility, Limitations, and Future of Non-Human Primates for Dengue Research and Vaccine Development

Dengue is considered the most important emerging, human arboviruses, with worldwide distribution in the tropics. Unfortunately, there are no licensed dengue vaccines available or specific anti-viral drugs. The development of a dengue vaccine faces unique challenges. The four serotypes co-circulate i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sariol, Carlos A., White, Laura J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174039/ https://www.ncbi.nlm.nih.gov/pubmed/25309540 http://dx.doi.org/10.3389/fimmu.2014.00452

Ejemplares similares

A Rapid Immunization Strategy with a Live-Attenuated Tetravalent Dengue Vaccine Elicits Protective Neutralizing Antibody Responses in Non-Human Primates
por: Ambuel, Yuping, et al.
Publicado: (2014)

Erratum: A Rapid Immunization Strategy with a Live-Attenuated Tetravalent Dengue Vaccine Elicits Protective Neutralizing Antibody Responses in Non-Human Primates
Publicado: (2014)

CCHFV vaccine development, current challenges, limitations, and future directions
por: Ahata, Büşra, et al.
Publicado: (2023)

Norovirus Vaccine: Priorities for Future Research and Development
por: Esposito, Susanna, et al.
Publicado: (2020)

Screening for immune response against Dengue virus in Vietnamese non-human primates: implications for vaccine developers
por: Lazo Vázquez, Laura, et al.
Publicado: (2017)

Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model
por: Carvalho-Queiroz, Claudia, et al.
Publicado: (2015)

A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates
por: Medina, Liana O., et al.
Publicado: (2018)

Plague Vaccine Development: Current Research and Future Trends
por: Verma, Shailendra Kumar, et al.
Publicado: (2016)

IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates
por: Logerot, Sandrine, et al.
Publicado: (2021)

Recent Developments in Recombinant Protein–Based Dengue Vaccines
por: Tripathi, Nagesh K., et al.
Publicado: (2018)

Anti-dengue Vaccines: From Development to Clinical Trials
por: Pinheiro-Michelsen, Josilene Ramos, et al.
Publicado: (2020)

Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines
por: Hou, Jue, et al.
Publicado: (2022)

Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates
por: White, Andrew D., et al.
Publicado: (2023)

An Evaluation of 20 Years of EU Framework Programme-Funded Immune-Mediated Inflammatory Translational Research in Non-Human Primates
por: Haanstra, Krista G., et al.
Publicado: (2016)

Of Monkeys and Men: Immunomic Profiling of Sera from Humans and Non-Human Primates Resistant to Schistosomiasis Reveals Novel Potential Vaccine Candidates
por: Pearson, Mark S., et al.
Publicado: (2015)

An imaging mass cytometry immunophenotyping panel for non-human primate tissues
por: Niewold, Paula, et al.
Publicado: (2022)

Editorial: Understanding the Limitations of Current Influenza Vaccine Strategies and Future Development of More Efficacious Preventative and Therapeutic Interventions
por: Tripp, Ralph A., et al.
Publicado: (2019)

Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity
por: Izmirly, Abdullah M., et al.
Publicado: (2020)

A Comprehensive Atlas of Immunological Differences Between Humans, Mice, and Non-Human Primates
por: Bjornson-Hooper, Zachary B., et al.
Publicado: (2022)

Dengue vaccine development: status and future
por: Wilder-Smith, Annelies
Publicado: (2019)

Cytokine-Mediated Tissue Injury in Non-human Primate Models of Viral Infections
por: Manickam, Cordelia, et al.
Publicado: (2018)

How to Model Rheumatoid Arthritis in Animals: From Rodents to Non-Human Primates
por: Zhao, Ting, et al.
Publicado: (2022)

Effects of Age and Social Adversity on Immune Cell Populations in a Non-Human Primate Model of Human Aging
por: Sanchez-Rosado, Mitchell, et al.
Publicado: (2021)

The Frequencies of Immunosuppressive Cells in Adipose Tissue Differ in Human, Non-human Primate, and Mouse Models
por: Laparra, Ariane, et al.
Publicado: (2019)

Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies
por: Clegg, Jonah, et al.
Publicado: (2021)

A therapeutic vaccine strategy to prevent Pneumocystis pneumonia in an immunocompromised host in a non-human primate model of HIV and Pneumocystis co-infection
por: Rabacal, Whitney, et al.
Publicado: (2022)

No monkey business: why studying NK cells in non-human primates pays off
por: Hong, Henoch S., et al.
Publicado: (2013)

Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
por: Alexandre, Marie, et al.
Publicado: (2022)

Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development
por: Elong Ngono, Annie, et al.
Publicado: (2019)

Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates
por: Bekri, Selma, et al.
Publicado: (2017)

Understanding the Role of Mucosal-Associated Invariant T-Cells in Non-human Primate Models of HIV Infection
por: Barber-Axthelm, Isaac M., et al.
Publicado: (2020)

Proteomics Analysis of Aqueous Humor and Rejected Graft in Pig-to-Non-Human Primate Corneal Xenotransplantation
por: Oh, Jae Won, et al.
Publicado: (2022)

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
por: Dussupt, Vincent, et al.
Publicado: (2021)

Development of a tetravalent subunit vaccine against dengue virus through a vaccinomics approach
por: Basheer, Amina, et al.
Publicado: (2023)

Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model
por: Lorenzen, Emma, et al.
Publicado: (2022)

Can non-human primates serve as models for investigating dengue disease pathogenesis?
por: Clark, Kristina B., et al.
Publicado: (2013)

Fully Human Monoclonal Antibody Inhibitors of the Neonatal Fc Receptor Reduce Circulating IgG in Non-Human Primates
por: Nixon, Andrew E., et al.
Publicado: (2015)

New-age vaccine adjuvants, their development, and future perspective
por: Verma, Shailendra Kumar, et al.
Publicado: (2023)

Monkeying Around: Using Non-human Primate Models to Study NK Cell Biology in HIV Infections
por: Manickam, Cordelia, et al.
Publicado: (2019)

Enhanced Delivery of Rituximab Into Brain and Lymph Nodes Using Timed-Release Nanocapsules in Non-Human Primates
por: Qin, Meng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pphpf815n0sv6ucfig54nchldr